Kuniaki Arai

5.1k total citations
130 papers, 3.3k citations indexed

About

Kuniaki Arai is a scholar working on Hepatology, Epidemiology and Oncology. According to data from OpenAlex, Kuniaki Arai has authored 130 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Hepatology, 50 papers in Epidemiology and 33 papers in Oncology. Recurrent topics in Kuniaki Arai's work include Liver Disease Diagnosis and Treatment (39 papers), Hepatocellular Carcinoma Treatment and Prognosis (31 papers) and Immunotherapy and Immune Responses (20 papers). Kuniaki Arai is often cited by papers focused on Liver Disease Diagnosis and Treatment (39 papers), Hepatocellular Carcinoma Treatment and Prognosis (31 papers) and Immunotherapy and Immune Responses (20 papers). Kuniaki Arai collaborates with scholars based in Japan, United States and Germany. Kuniaki Arai's co-authors include Tatsuya Yamashita, Eishiro Mizukoshi, Shuichi Kaneko, Masao Honda, Taro Yamashita, Yoshio Sakai, Shuichi Kaneko, Takeshi Terashima, Yasunari Nakamoto and Masaaki Kitahara and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Kuniaki Arai

123 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kuniaki Arai Japan 32 1.2k 1.2k 968 862 780 130 3.3k
Masanori Matsuda Japan 36 1.7k 1.4× 1.4k 1.2× 858 0.9× 879 1.0× 768 1.0× 134 4.2k
Bryan C. Fuchs United States 40 1.2k 1.0× 1.4k 1.1× 1.0k 1.1× 205 0.2× 1.7k 2.2× 105 4.7k
Bernd Kronenberger Germany 35 1.4k 1.1× 1.3k 1.1× 403 0.4× 371 0.4× 1.3k 1.7× 104 3.4k
Tiziana Camerini Italy 27 1.2k 1.0× 928 0.8× 1.2k 1.3× 306 0.4× 1.2k 1.5× 39 3.5k
Enrico N. De Toni Germany 26 1.1k 0.9× 712 0.6× 1.2k 1.2× 489 0.6× 1.3k 1.6× 107 3.5k
Loreto Boix Spain 29 2.7k 2.1× 1.9k 1.6× 845 0.9× 184 0.2× 1.1k 1.4× 68 4.4k
Guido Hartmann Switzerland 22 1.1k 0.9× 274 0.2× 570 0.6× 313 0.4× 1.4k 1.8× 38 3.4k
Takashi Kijima Japan 26 508 0.4× 251 0.2× 1.4k 1.4× 392 0.5× 1.3k 1.7× 167 3.4k
Zhao–You Tang China 38 2.0k 1.6× 911 0.8× 1.5k 1.6× 622 0.7× 2.4k 3.1× 164 5.7k
Kaoru Tsuchiya Japan 30 2.5k 2.0× 2.0k 1.7× 305 0.3× 111 0.1× 256 0.3× 140 3.2k

Countries citing papers authored by Kuniaki Arai

Since Specialization
Citations

This map shows the geographic impact of Kuniaki Arai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kuniaki Arai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kuniaki Arai more than expected).

Fields of papers citing papers by Kuniaki Arai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kuniaki Arai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kuniaki Arai. The network helps show where Kuniaki Arai may publish in the future.

Co-authorship network of co-authors of Kuniaki Arai

This figure shows the co-authorship network connecting the top 25 collaborators of Kuniaki Arai. A scholar is included among the top collaborators of Kuniaki Arai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kuniaki Arai. Kuniaki Arai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Terashima, Takeshi, Tatsuya Yamashita, Kuniaki Arai, et al.. (2024). Comprehensive genomic profiling for advanced hepatocellular carcinoma in clinical practice. Hepatology International. 19(1). 212–221. 3 indexed citations
2.
Takeshita, Yumie, Hiroaki Takayama, Hisanori Goto, et al.. (2023). Trajectories of Liver Fibrosis and Gene Expression Profiles in Nonalcoholic Fatty Liver Disease Associated With Diabetes. Diabetes. 72(9). 1297–1306. 12 indexed citations
3.
Li, Ru, Hikari Okada, Taro Yamashita, et al.. (2022). FOXM1 Is a Novel Molecular Target of AFP-Positive Hepatocellular Carcinoma Abrogated by Proteasome Inhibition. International Journal of Molecular Sciences. 23(15). 8305–8305. 10 indexed citations
4.
Iida, Noriho, Eishiro Mizukoshi, Tatsuya Yamashita, et al.. (2021). Chronic liver disease enables gut Enterococcus faecalis colonization to promote liver carcinogenesis. Nature Cancer. 2(10). 1039–1054. 55 indexed citations
5.
6.
Terashima, Takeshi, Tatsuya Yamashita, Tatsuya Yamashita, et al.. (2020). Safety and efficacy of sorafenib followed by regorafenib or lenvatinib in patients with hepatocellular carcinoma. Hepatology Research. 51(2). 190–200. 8 indexed citations
7.
Yamashita, Taro, Hikari Okada, Kouki Nio, et al.. (2020). Inactivation of Transcriptional Repressor Capicua Confers Sorafenib Resistance in Human Hepatocellular Carcinoma. Cellular and Molecular Gastroenterology and Hepatology. 10(2). 269–285. 12 indexed citations
8.
Yamada, Kazutoshi, Eishiro Mizukoshi, Takuya Seike, et al.. (2019). Serum C16:1n7/C16:0 ratio as a diagnostic marker for non‐alcoholic steatohepatitis. Journal of Gastroenterology and Hepatology. 34(10). 1829–1835. 23 indexed citations
9.
Yamada, Kazutoshi, Eishiro Mizukoshi, Takuya Seike, et al.. (2018). Light alcohol consumption has the potential to suppress hepatocellular injury and liver fibrosis in non-alcoholic fatty liver disease. PLoS ONE. 13(1). e0191026–e0191026. 30 indexed citations
10.
Mizukoshi, Eishiro, Takeshi Terashima, Masaaki Kitahara, et al.. (2018). Immune responses against tumour‐associated antigen‐derived cytotoxic T lymphocyte epitopes in cholangiocarcinoma patients. Liver International. 38(11). 2040–2050. 14 indexed citations
11.
Terashima, Takeshi, Tatsuya Yamashita, Tatsuya Yamashita, et al.. (2018). Analysis of the liver functional reserve of patients with advanced hepatocellular carcinoma undergoing sorafenib treatment: Prospects for regorafenib therapy. Hepatology Research. 48(12). 956–966. 30 indexed citations
12.
Terashima, Takeshi, Tatsuya Yamashita, Tatsuya Yamashita, et al.. (2016). Response to chemotherapy improves hepatic reserve for patients with hepatocellular carcinoma and Child–Pugh B cirrhosis. Cancer Science. 107(9). 1263–1269. 19 indexed citations
13.
Terashima, Takeshi, Tatsuya Yamashita, Tatsuya Yamashita, et al.. (2015). Post‐progression survival and progression‐free survival in patients with advanced hepatocellular carcinoma treated by sorafenib. Hepatology Research. 46(7). 650–656. 43 indexed citations
14.
Terashima, Takeshi, Tatsuya Yamashita, Noriho Iida, et al.. (2014). Blood neutrophil to lymphocyte ratio as a predictor in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy. Hepatology Research. 45(9). 949–959. 45 indexed citations
15.
Honda, Masao, Akihiro Tanaka, Yoshimoto Nomura, et al.. (2013). Association of Interleukin-28B Genotype and Hepatocellular Carcinoma Recurrence in Patients with Chronic Hepatitis C. Clinical Cancer Research. 19(7). 1827–1837. 55 indexed citations
16.
Nomura, Yoshimoto, Takashi Kagaya, Teruyuki Ueda, et al.. (2012). The biliary drainage for patients with obstructive jaundice due to hepatocellular carcinoma. Kanzo. 53(11). 734–740. 1 indexed citations
17.
Terashima, Takeshi, Tatsuya Yamashita, Kuniaki Arai, et al.. (2007). A case of metastatic gallbladder tumor of the hepatocellular carcinoma. Kanzo. 48(8). 363–369. 5 indexed citations
18.
Shimakami, Tetsuro, Tatsuya Yamashita, Yoshio Sakai, et al.. (2007). A case of primary biliary cirrhosis with progressive jaundice due to Basedow's disease. Kanzo. 48(9). 452–457.
19.
Shilagardi, Khurts, Kenkichi Masutomi, Delgermaa Luvsanjav, et al.. (2006). Nucleolin interacts with telomerase. Kanazawa University Repository for Academic Resources (DSpace) (Kanazawa University). 95 indexed citations
20.
Arai, Kuniaki, et al.. (2003). Two independent regions of human telomerase reverse transcriptase (hTERT) are important for its oligomerization and telomerase activity. 2000. 10. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masanori Matsuda Breakdown of academic impact, for papers by Bryan C. Fuchs Breakdown of academic impact, for papers by Bernd Kronenberger Breakdown of academic impact, for papers by Tiziana Camerini Breakdown of academic impact, for papers by Enrico N. De Toni Breakdown of academic impact, for papers by Loreto Boix Breakdown of academic impact, for papers by Guido Hartmann Breakdown of academic impact, for papers by Takashi Kijima Breakdown of academic impact, for papers by Zhao–You Tang Breakdown of academic impact, for papers by Kaoru Tsuchiya
Rankless by CCL
2026